CopyFind
← К поиску
KALETRA
medicine 📍 CA

KALETRA

Аналоги KALETRA

Найдите более доступные аналоги и дженерики для KALETRA.

Ингредиенты

Активный ингредиент: LOPINAVIR, RITONAVIR


Описание товара

About KALETRA

KALETRA is a prescription medication containing the active ingredients Lopinavir and Ritonavir, used in combination with other medications to treat HIV-1 infection in adults and children. It is a protease inhibitor, which works by blocking the protease enzyme that the virus needs to replicate.

Key Benefits & Uses

  • Treatment of HIV-1 infection in adults and children.
  • Combination therapy for HIV-1 infection, used in conjunction with other medications.
  • Part of an antiretroviral regimen to manage HIV-1 infection and prevent progression to AIDS.

Active Ingredient & Action

LOPINAVIR and RITONAVIR are protease inhibitors that work by blocking the protease enzyme, which is essential for the replication of the HIV-1 virus. By inhibiting this enzyme, LOPINAVIR and RITONAVIR prevent the virus from multiplying and reduce the viral load in the body.

Important Notes

KALETRA should only be used under the guidance of a healthcare professional and as part of a comprehensive treatment plan. It is essential to follow the prescribed dosage and treatment regimen to ensure effective treatment and minimize the risk of side effects. Regular monitoring of viral load and CD4 cell count is recommended to assess the effectiveness of treatment.

Оценки посетителей

Помогите другим — оцените полезность этой страницы.

Оценок пока нет — будьте первым.

Похожие товары и аналоги

Norvir

Активн.: ritonavir

Совпадение: 100% Сравнить →
НОРВІР

Активн.: Ritonavir

Совпадение: 100% Сравнить →
РИТОВІР

Активн.: Ritonavir

Совпадение: 100% Сравнить →
Ritonavir

Активн.: Ritonavir

Совпадение: 100% Сравнить →
AURO-RITONAVIR

Активн.: RITONAVIR

Совпадение: 100% Сравнить →
Ritonavir Viatris (previously Ritonavir Mylan)

Активн.: ritonavir

Совпадение: 100% Сравнить →
PAXLOVID

Активн.: RITONAVIR, NIRMATRELVIR

Совпадение: 33% Сравнить →